Home / Eplerenone / Canada
CA ATC C03DA04 · updated 2 Nov 2026
Eplerenone shortage in Canada
Is there an Eplerenone shortage in Canada?
Yes. As of 2 Nov 2026, 2 Eplerenone products are reported short in Canada, the first since 15 Sep 2026. The company estimate for the return is 12 Jan 2027 (latest 22 Jan 2027). Main reason: manufacturing problem.
Also short in Italy, Spain, Austria, Belgium, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | JAMP EPLERENONE (Blister 3 x 10) | JAMP PHARMA CORPORATION | 15 Sep 2026 | 22 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | INSPRA (3x10 BLST) anticipated | BGP PHARMA ULC | 20 Nov 2026 | 12 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.